Amplity Health, a pure-play pharmaceutical commercialisation organisation, has named Becky O'Loughlin, Tracy Hervey and Morayea Pindziak as its new chief people officer; chief commercial officer and global head of Marketing & Communications respectively, it was reported on Thursday.
O'Loughlin has more than 20 years of human capital experience and was most recently at Qurate Retail Group where she served as senior vice president of People. There she directed the enterprise people strategy and managed the delivery of people solutions globally across several retail brands including QVC, Zulily and HSN.
Hervey has more than 20 years of industry experience and is responsible for driving the success of the entire commercial team across all of Amplity's capabilities, while playing a key role in setting strategy for the company's growth and expansion. Most recently, Hervey served as vice president, Global Accounts for ICON plc. Prior to ICON, Hervey held leadership roles of increasing responsibility at both IQVIA and PPD Inc, where she was also responsible for market & sales growth strategies, partnership conversions and expansion and building effective sales teams.
Pindziak has more than a decade of healthcare industry experience as the head marketing resource for various agencies and consultancies, she has built brands from the ground up. Pindziak joins from HealixGlobal, where she was vice president, Marketing & Operations and she served as a key member of the leadership team with responsibility for marketing, communications, employee engagement and corporate culture.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer